Poll Finds Most Veterans Back Recreational, Medical Cannabis
A poll reported Oct. 19 shows majority veteran support for both adult-use and medical legalization, sharpening pressure on VA policy and MSO medical strategy.

American flag and Veterans Day text on tiles symbolizing honor and patriotism.
Majority backing spans both adult-use and medical
The poll found most veterans support legalization on both the recreational and medical tracks, according to Marijuana Moment's Oct. 19, 2026 report.
That two-part result is the story. Medical-only support is the comfortable position for politicians, because it lets them back patients without endorsing the adult-use market. Majority support for recreational legalization removes that hedge.
One caveat up front. The summary CannIntel reviewed didn't include the poll's sponsor, sample size, margin of error or topline percentages, so we won't supply numbers that aren't in the record. Check the full Marijuana Moment report for methodology before citing a figure.
The thesis: this poll is about messengers, not math
The poll matters less as a demographic data point than as a credibility asset for legalization campaigns and the lawmakers who back them.
Here's my read. Veterans are a small slice of the electorate, but they carry unusual weight with lawmakers in both parties. A legislator can dismiss a generic poll of adults. Dismissing the people who served is harder.
That's why veteran testimony has anchored so many access arguments, especially around PTSD and chronic pain. A majority-support finding makes the messenger stronger, whatever the exact percentage turns out to be.
The VA policy gap this poll exposes
The Department of Veterans Affairs still doesn't allow its clinicians to recommend medical cannabis or complete state program paperwork, though veterans don't lose VA benefits for state-legal use.
The restriction traces to federal law. Cannabis remains controlled at the federal level, and VA is a federal health system. Veterans in states with medical programs, such as California and Ohio, generally have to find a private physician and pay out of pocket for the evaluation.
Congress has debated the issue repeatedly. Nothing has changed the basic bind: the population most likely to say it wants access is the one whose primary health system can't help it get there.
That gap is hard to defend.
What it means for MSOs and veteran-focused brands
For operators, the poll validates veteran outreach as a durable retail and medical-program strategy, but it doesn't loosen advertising or health-claim rules.
Veteran discounts are already a common feature of dispensary loyalty programs. The poll suggests that's more than a feel-good tactic. It's a way to build loyalty with a customer base that is, by its own stated preference, pro-legalization.
Watch the competitive angle. MSOs with deep medical footprints can credibly pitch themselves as the access point the VA can't be, while adult-use-only players have less to say to this customer. Medical patients also tend to buy more consistently than casual adult-use shoppers (a pattern operators in mature markets know well), so the segment is worth the effort.
The guardrails haven't moved. State regulators still police therapeutic claims, and a poll isn't evidence that a product treats PTSD. Marketing that implies otherwise invites enforcement. Taxes and 280E pressure also leave little margin for discount programs that aren't tightly managed.
The federal variable still controls the outcome
Any durable change to VA policy depends on federal action, which runs through the DEA's scheduling decisions and through Congress.
State legalization can expand the pool of veterans who live in access states. It can't rewrite how a federal health agency practices medicine. Only a change in federal status or a direct statutory fix to VA's restrictions does that.
That's the practical ceiling on this poll's impact. It can shift the political climate. It can't, by itself, shift the rules. For full background on this story, see the CannIntel topic hub on veterans and cannabis access.
What to watch next
The next indicators are the poll's full methodology, any lawmaker response, and whether advocates tie the result to pending VA-related legislation.
Start with the sponsor and sample. A poll from a veterans' organization carries a different weight than one commissioned by a cannabis trade group. Both can be accurate, but they get used differently.
Then watch for congressional staff and campaigns picking it up. If this number shows up in a committee hearing or a floor speech, the messenger thesis holds. If it fades in a news cycle, it was a headline and nothing more.
For complete background, history, and our ongoing coverage of this story:
Open the CannIntel topic hub →Frequently asked questions
What did the new veterans cannabis poll find?
According to Marijuana Moment's Oct. 19, 2026 report, most military veterans support legalizing marijuana for both recreational and medical use. The summary CannIntel reviewed did not include exact percentages, sample size or the sponsoring organization.
Can VA doctors recommend medical marijuana to veterans?
No. VA policy doesn't allow its clinicians to recommend medical cannabis or complete paperwork for state programs, because cannabis remains controlled under federal law. Veterans in state programs typically use private physicians.
Do veterans lose VA benefits for using state-legal cannabis?
VA policy says veterans aren't denied VA benefits solely because they use cannabis in compliance with state law. Veterans are generally encouraged to talk openly with their VA providers about any use.
Why does a veterans poll matter for cannabis policy?
Veterans carry credibility with lawmakers in both parties, and access arguments around PTSD and chronic pain often center on their experience. A majority-support finding strengthens that messaging, though it doesn't change federal law.
What does the poll mean for cannabis operators?
It supports veteran outreach and medical-program strategies, such as discounts and access-focused marketing. It doesn't relax state rules on health claims, so operators still can't imply products treat specific conditions.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from News

AZmarijuana.com Reports Teen Use Fell in Adult-Use States
A published report says youth cannabis use declined significantly in legalization states, but the underlying survey, figures and time frame weren't available for verification.

California Man Punished in Remote Cannabis Farm Imprisonment Case
The New York Post reported a California man was punished for imprisoning migrants on a remote weed farm, but sentence and charge details remain unconfirmed.

Colorado Cannabis Vape Recall Expands as Health Complaints Rise
MJBizDaily reported Oct. 15 that the Colorado vape recall widened as complaints grew; key details on scope remain unpublished.
More from the newsroom

Jersey Set to Tighten Medical Cannabis Prescribing Rules
Cannabis Health News reported Oct. 19 that Jersey will tighten medical cannabis prescribing, but the scope, authority and start date remain unpublished.

Altadena Cannabis Zoning Comments Due Tuesday Noon, County Says
Altadena residents have until noon Tuesday to weigh in on cannabis zoning before county commissioners act, according to a Pasadena Now report.

Avicanna Medical Platform Sales Jump 42% as It Bets on U.S. Reform
Kalkine.ca reports a 42% rise in Avicanna's medical platform sales, but the headline omits the dollar base, the period and the cost of its clinical-trial push.